Sun Pharma to shut down Caraco's US plant
The move is a result of the company's strategy to consolidate its manufacturing activity in the US
BS B2B Bureau B2B Connect | Mumbai
However, in October, Sun Pharma had said that it addressed the US health regulator's concerns about manufacturing lapses at the plant and continued production.
In a press release on May 2, 2014, Sun Pharma stated, “It has notified the Workforce Development Agency for the State of Michigan regarding its decision to cease manufacturing operations and close the Detroit (Caraco Pharmaceutical) facility located at Elijah McCoy Detroit, Ml, USA. The company has provided the requisite advance written notice of the facility closure to the employee union and all affected employees.”
Also Read
Sun Pharma has undertaken necessary measures to ensure business continuity of the products being manufactured at this facility. The manufacturing of these products is being transferred to other units and all necessary steps have been taken to avoid market shortage. Sun Pharma expects a negligible impact of this development on its FY15 consolidated revenues.
For the year ending March 2013, Sun Pharma had registered an overall revenues of $2.1 billion, of which US contributed $1.1 billion.
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: May 05 2014 | 11:11 AM IST